The Hottest Pot Stock to Watch in 2021
With industry veterans on board and a unique strategy that could position the company to becoming the premium cannabis brand in Canada, this small-cap player looks on the verge of being discovered!
Continue Reading

CASI Insider Trading (CASI Pharmaceuticals)

Insider Ownership Percentage: 24.75%
Insider Buying (Last 12 Months): $7,937,567.83
Insider Selling (Last 12 Months): $0.00

CASI Pharmaceuticals Insider Trading History Chart

CASI Pharmaceuticals Share Price & Price History

▲ +0.08 (3.25%)
As of 03/1/2021 01:00 AM ET
Days: 30 | 90 | 365
Buffett Dumps $800M Of Apple, Buys This Instead!
Warren Buffett recently dumped $800 million of Apple stock…

He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…
What does Buffett know?

CASI Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/16/2020Weihao XuCFOBuy2,000$2.44$4,880.00  
7/22/2020Larry ZhangPresidentBuy20,153$1.90$38,290.7020,153  
7/22/2020Wei-Wu HeCEOBuy2,952,426$1.90$5,609,609.404,836,523  
5/20/2020Wei-Wu HeCEOBuy86,265$2.61$225,151.651,827,663  
5/18/2020Wei-Wu HeCEOBuy438,932$2.05$899,810.601,827,663  
3/27/2020Wei-Wu HeCEOBuy6,880$2.09$14,379.201,358,900  
3/25/2020Wei-Wu HeCEOBuy196,398$1.94$381,012.121,023,925  
3/19/2020Wei-Wu HeCEOBuy234,488$1.57$368,146.16827,527  
3/17/2020Wei-Wu HeCEOBuy264,192$1.50$396,288.00827,527  
8/16/2019Wei-Wu HeCEOBuy20,000$3.20$64,000.00827,527  
8/14/2019Brian D ColemanCFOBuy20,000$2.44$48,800.00
8/14/2019Wei-Wu HeCEOBuy160,000$3.17$507,200.00807,527  
3/21/2018China Growth Fund Idg-Accel IIMajor ShareholderBuy3,086,418$3.19$9,845,673.42  
3/19/2018Wei-Wu HeDirectorBuy3,086,419$3.24$9,999,997.56847,527  
See Full Table

SEC Filings (Institutional Ownership Changes) for CASI Pharmaceuticals (NASDAQ:CASI)

31.95% of CASI Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CASI Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/25/2021Dimensional Fund Advisors LP30,290$89K0.0%N/A0.024%
2/24/2021Virtu Financial LLC12,450$37K0.0%-67.7%0.010%
2/23/2021Principal Financial Group Inc.14,414$43K0.0%N/A0.012%
2/19/2021JPMorgan Chase & Co.183,922$0.54M0.0%+281.1%0.148%
2/16/2021Price T Rowe Associates Inc. MD112,917$0.33M0.0%+53.7%0.091%
2/16/2021Charles Schwab Investment Management Inc.480,106$1.42M0.0%+1.7%0.387%
2/12/2021Federated Hermes Inc.7,000,000$20.65M0.0%+1.4%5.648%
2/12/2021The Manufacturers Life Insurance Company 45,064$0.13M0.0%+121.5%0.036%
2/12/2021Ikarian Capital LLC1,268,154$3.74M0.2%-17.6%1.023%
2/12/2021Credit Suisse AG19,406$57K0.0%N/A0.016%
2/11/2021Northern Trust Corp940,103$2.77M0.0%+3.8%0.758%
2/11/2021Barclays PLC21,341$63K0.0%-28.3%0.017%
2/11/2021Citigroup Inc.11,781$35K0.0%+271.1%0.010%
2/10/2021Rhumbline Advisers73,286$0.22M0.0%+11.5%0.059%
2/10/2021Renaissance Technologies LLC70,813$0.21M0.0%-88.2%0.057%
2/9/2021Wells Fargo & Company MN169,768$0.50M0.0%+4.2%0.137%
2/9/2021Bank of New York Mellon Corp187,679$0.55M0.0%+6.8%0.151%
2/9/2021Wellington Shields Capital Management LLC2,071,765$6.11M0.8%+45.4%1.672%
2/9/2021Wellington Shields & Co. LLC1,812,769$5.35M1.9%+22.5%1.463%
2/9/2021ProShare Advisors LLC14,651$43K0.0%N/A0.012%
2/5/2021BlackRock Inc.3,830,466$11.30M0.0%+9.1%3.090%
2/4/2021GSA Capital Partners LLP52,146$0.15M0.0%+157.4%0.042%
2/4/2021State of Wisconsin Investment Board91,900$0.27M0.0%N/A0.074%
12/11/2020Virtu Financial LLC38,496$59K0.0%N/A0.031%
11/16/2020Squarepoint Ops LLC19,637$30K0.0%N/A0.016%
11/16/2020Boothbay Fund Management LLC196,653$0.30M0.0%+41.3%0.159%
11/16/2020Consonance Capital Management LP6,560,000$10.04M1.2%N/A5.293%
11/13/2020Charles Schwab Investment Management Inc.471,893$0.72M0.0%+40.9%0.381%
11/12/2020Federated Hermes Inc.6,900,000$10.56M0.0%N/A5.567%
11/10/2020State Street Corp1,017,612$1.56M0.0%+6.5%0.821%
11/9/2020The Manufacturers Life Insurance Company20,343$31K0.0%-44.7%0.016%
11/6/2020BlackRock Inc.3,511,724$5.37M0.0%+1.0%2.833%
11/6/2020GSA Capital Partners LLP20,260$31K0.0%N/A0.016%
11/4/2020American International Group Inc.39,530$61K0.0%+20.1%0.032%
10/30/2020WINTON GROUP Ltd76,830$0.12M0.0%-25.5%0.062%
8/31/2020Bridgeway Capital Management Inc.205,200$0.51M0.0%+42.4%0.166%
8/25/2020Nuveen Asset Management LLC181,672$0.46M0.0%-5.9%0.147%
8/20/2020Charles Schwab Investment Management Inc.334,796$0.84M0.0%+9.8%0.270%
8/17/2020Jane Street Group LLC12,552$31K0.0%N/A0.010%
8/14/2020Bank of America Corp DE18,490$46K0.0%+103.7%0.015%
8/12/2020Goldman Sachs Group Inc.11,621$29K0.0%-60.1%0.010%
8/12/2020Bank of New York Mellon Corp174,643$0.44M0.0%+4.0%0.144%
8/5/2020Wellington Shields & Co. LLC1,585,609$3.96M1.7%+20.5%1.311%
8/5/2020Wellington Shields Capital Management LLC1,321,745$3.30M0.5%+0.5%1.093%
8/5/2020WINTON GROUP Ltd103,059$0.26M0.0%+20.5%0.085%
7/31/2020UBS Group AG17,158$43K0.0%-42.2%0.014%
7/24/2020Heritage Investors Management Corp27,585$69K0.0%+48.5%0.027%
7/17/2020Vident Investment Advisory LLC67,540$0.17M0.0%-21.1%0.067%
6/19/2020State Street Corp907,963$1.85M0.0%-4.6%0.900%
6/16/2020Royal Bank of Canada37,889$77K0.0%+82.0%0.038%
5/18/2020Zebra Capital Management LLC52,517$0.11M0.2%+18.6%0.052%
5/15/2020Ikarian Capital LLC1,039,910$2.12M0.2%N/A1.030%
5/14/2020Geode Capital Management LLC705,108$1.44M0.0%+3.5%0.699%
5/14/2020Alliancebernstein L.P.59,000$0.12M0.0%+20.9%0.058%
5/13/2020Parametric Portfolio Associates LLC26,404$54K0.0%+35.9%0.026%
5/13/2020BNP Paribas Arbitrage SA15,473$32K0.0%+111.1%0.015%
5/13/2020IHT Wealth Management LLC24,000$49K0.0%-20.0%0.024%
5/12/2020Vident Investment Advisory LLC85,568$0.18M0.0%+25.1%0.085%
5/12/2020JPMorgan Chase & Co.40,125$82K0.0%+31.5%0.040%
5/11/2020Wellesley Investment Partners LLC15,000$30K0.0%N/A0.015%
5/11/2020State Street Corp907,963$1.85M0.0%-4.6%0.900%
5/11/2020WINTON GROUP Ltd85,525$0.17M0.0%+45.6%0.085%
5/6/2020Bank of New York Mellon Corp167,862$0.34M0.0%+5.1%0.166%
5/6/2020Heritage Investors Management Corp18,579$38K0.0%+84.0%0.018%
5/2/2020SG Americas Securities LLC18,274$37K0.0%N/A0.018%
5/1/2020BlackRock Inc.3,251,569$6.63M0.0%-1.0%3.222%
5/1/2020UBS Group AG29,673$61K0.0%-55.8%0.029%
2/17/2020Zebra Capital Management LLC44,294$0.14M0.1%N/A0.046%
2/14/2020Bank of America Corp DE16,565$51K0.0%-27.2%0.017%
2/14/2020IDG Accel China Growth Fund III Associates L.P.7,973,536$24.64M8.8%N/A8.276%
2/14/2020Goldman Sachs Group Inc.47,899$0.15M0.0%+37.3%0.050%
2/14/2020UBS Group AG67,101$0.21M0.0%+61.5%0.070%
2/11/2020Wellington Shields & Co. LLC1,277,322$3.95M1.7%N/A1.326%
2/11/2020Vident Investment Advisory LLC68,414$0.21M0.0%+41.3%0.071%
2/10/2020Barclays PLC50,431$0.16M0.0%+102.9%0.052%
2/7/2020Charles Schwab Investment Management Inc.300,542$0.93M0.0%+9.9%0.312%
2/6/2020State Street Corp951,326$2.94M0.0%+8.7%0.987%
1/27/2020California Public Employees Retirement System128,018$0.40M0.0%-7.4%0.133%
11/27/2019Barclays PLC24,859$83K0.0%-23.5%0.026%
11/27/2019State Street Corp875,142$2.92M0.0%+0.5%0.908%
11/5/2019Wellington Shields Capital Management LLC1,315,077$4.39M0.7%+15.2%1.374%
8/16/2019Susquehanna International Group LLP25,220$81K0.0%N/A0.026%
8/15/2019Jane Street Group LLC10,887$35K0.0%N/A0.011%
8/14/2019AQR Capital Management LLC38,062$0.12M0.0%-23.4%0.040%
8/13/2019BlackRock Inc.3,111,073$9.96M0.0%+13.6%3.250%
8/13/2019Northern Trust Corp606,766$1.94M0.0%+1.0%0.634%
8/10/2019Charles Schwab Investment Management Inc.313,252$1M0.0%+23.4%0.327%
8/8/2019Wellington Shields Capital Management LLC1,141,237$3.65M0.6%-0.4%1.192%
8/6/2019Wells Fargo & Company MN72,643$0.23M0.0%+13.7%0.076%
6/16/2019Marshall Wace LLP15,247$44K0.0%N/A0.016%
5/10/2019Wellington Shields Capital Management LLC1,145,949$3.29M0.6%-2.6%1.197%
5/10/2019Wellington Shields & Co. LLC1,126,650$3.23M1.6%+4.3%1.177%
5/1/2019Alps Advisors Inc.230,154$0.66M0.0%+4.5%0.240%
4/25/2019BNP Paribas Arbitrage SA10,369$30K0.0%N/A0.011%
4/9/2019Heritage Investors Management Corp10,095$29K0.0%N/A0.011%
4/1/2019Deutsche Bank AG65,226$0.26M0.0%-34.8%0.068%
2/15/2019IHT Wealth Management LLC23,725$95K0.0%+121.2%0.025%
2/14/2019Metropolitan Life Insurance Co. NY18,946$76K0.0%+365.5%0.020%
2/14/2019MetLife Investment Advisors LLC26,316$0.11M0.0%-35.5%0.028%
2/14/2019Bank of America Corp DE28,954$0.12M0.0%+132.9%0.030%
Data available starting January 2016

See Full Table
CASI Pharmaceuticals logo
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical products and various therapeutics in China, the United States, and internationally. The company's product pipeline includes EVOMELA, a melphalan hydrochloride for injection primarily for use as a high-dose conditioning treatment prior to hematopoietic progenitor cell transplantation in patients with multiple myeloma. Its product pipeline also comprise CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma; CID-103, an anti-CD38 monoclonal antibody being for the treatment of patients with multiple myeloma; ZEVALIN, a CD20-directed radiotherapeutic antibody, to treat patients with NHL; and Thiotepa, a chemotherapeutic agent, which has multiple indications including use as a conditioning treatment for use prior to hematopoietic stem cell transplantation. In addition, the company offers MARQIBO, a microtubule inhibitor, approved by the FDA for the treatment of adult patients with Philadelphia chromosome-negative ALL; and Octreotide LAI formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumours, as well as developing a portfolio of 25 FDA-approved abbreviated new drug applications. It has licensing agreements with Black Belt Therapeutics Limited, Juventas Cell Therapy Ltd., and Pharmathen Global BV. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was founded in 1991 and is based in Rockville, Maryland.
Read More

Today's Range

Now: $2.54

50 Day Range

MA: $3.14

52 Week Range

Now: $2.54


246,825 shs

Average Volume

518,301 shs

Market Capitalization

$314.82 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of CASI Pharmaceuticals?

CASI Pharmaceuticals' top insider investors include:
  1. Wei-Wu He (CEO)
  2. Larry Zhang (President)
  3. Brian D Coleman (CFO)
  4. Weihao Xu (CFO)

Who are the major institutional investors of CASI Pharmaceuticals?

CASI Pharmaceuticals' top institutional investors include:
  1. Federated Hermes Inc. — 5.65%
  2. BlackRock Inc. — 3.09%
  3. Wellington Shields Capital Management LLC — 1.67%
  4. Wellington Shields & Co. LLC — 1.46%
  5. Ikarian Capital LLC — 1.02%
  6. Northern Trust Corp — 0.76%

Which major investors are selling CASI Pharmaceuticals stock?

In the previous quarter, CASI stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Ikarian Capital LLC
  3. Virtu Financial LLC
  4. Barclays PLC

Which major investors are buying CASI Pharmaceuticals stock?

In the last quarter, CASI stock was acquired by institutional investors including:
  1. Wellington Shields Capital Management LLC
  2. Wellington Shields & Co. LLC
  3. BlackRock Inc.
  4. JPMorgan Chase & Co.
  5. Federated Hermes Inc.
  6. State of Wisconsin Investment Board
  7. Price T Rowe Associates Inc. MD
  8. Northern Trust Corp
During the last year, these company insiders have bought CASI Pharmaceuticals stock:
  1. Wei-Wu He (CEO)
  2. Larry Zhang (President)
  3. Brian D Coleman (CFO)
  4. Weihao Xu (CFO)
The Hottest Pot Stock to Watch in 2021
With industry veterans on board and a unique strategy that could position the company to becoming the premium cannabis brand in Canada, this small-cap player looks on the verge of being discovered!
Continue Reading